Dezember 2021

INDEX

TRIBUNE LIBRE (page 4)
LE PLAISIR DE LA DONATION ... de DERMATOLOGICA HELVETICA
/ DERMATOLOGICA HELVETICA ... DIE FREUDE DER SCHENKUNG
Merci / Vielen Dank / Grazie / Grazcha fifich, Professor Saurat!

JOURNAL CLUB (page 10)
A Dermatologist Who Made a Spatial Mapping of His Long-term Recrudescent Herpes Simplex Labialis for 37 Years
Ex Vivo Dermoscopy in Demodecidosis
Histology of the Skin Without a Biopsy: Will Deep Learning Be Deep Enough?
Discovery of Proteins That Clean Sebum From Comedogenic Free Fatty Acids
Classification of Dermatological Diseases: a New Comprehensive Online Skin Disease Taxonomy Designed by and for Dermatologists. ICD11, the Who Official Statistical Classification of Skin Diseases
Editor's Note: the True Story Behind the Introduction of Dermatological Diseases in the Who’ International Classification of Diseases ICD11. How the Who Had Recognized Dermatology and Diseases of the Skin.

FOCUS (page 18)
Watchful Waiting Might Be an Appropriate Approach in Patients With BCC With a Limited Life Expectancy and Asymptomatic Nodular or Superficial BCCs
Mohs Micrographic Surgery Is Cost Effective for Intermediate-risk Squamous Cell Carcinoma
More and More Evidence Indicate That Sex Hormones Play Critical Roles in Skin Cancer
New Avenues for Systemic Photoprevention Based on Pharmaceuticals, Plant-derived Phytochemicals and Vitamins
Hyaluronic Acid Conjugates: a New Topical Treatment Specifically Designed to Improve Selectivity Toward Skin Cancers. Efficacy in the Absence of Inflammation

SGDV / SSDV (page 25)
ROTOKOLL der 103. Generalversammlung der SGDV
/ PROCÈS-VERBAL de la 103e Assemblée générale de la SSDV
Programme RRDV 2022

REPORTS (page 33)
Gliptine als möglicher Auslöser eines bullösen Pemphigoids
Tuberculosis Ulcer: The Never-ending Story
Schweizer Expertenmeinung zur Therapie mit Skilarence® (Dimethylfumarat) bei mittelschwerer bis schwerer Psoriasis vulgaris - Update 2021

Indistrie (page 37)
JAK-Inhibition bei atopischer Dermatitis. Baricitinib: Schnelle und starke Wirksamkeit auch in der Praxis
TILDRAKIZUMAB (ILUMETRI®) ÜBERZEUGT IN DER LANGZEITANWENDUNG IN KLINIK UND PRAXIS